Marc Pelletier Email & Phone Number | Biochemist/Cell Biologist with +20 years of biomedical research experience in industry settings, working on oncology, auto-immune and anti-fungal targets. Currently discovering, developing and implementing translational biomarkers of target engagement and patient stratification for clinical trials in immune oncology. Experienced in assay development to discover small molecule and protein therapeutics. Effective communicator, highly collaborative, engaging colleagues with complementary skills and knowledge to achieve project goals and timelines. Record of taking on and completing difficult projects: • Discovered and developed clinical biomarkers that have demonstrated pathway modulation in biopsies and sera from PhI trials of novel immune oncology molecules. • Designed and conducted experiments using preclinical models and human samples which led to translatable pharmacodynamic biomarkers for tumor autologous and microenvironment targets. • Developed a novel homologous recombination quantitative assay to support the PARP inhibitor Niraparib. • Developed scalable purification strategies and HTS amenable assays for multi-subunit enzyme complexes and high molecular weight kinases. • Published detailed comparison of two BAFF pathway decoy receptors used to assess putative drug candidates. • Utilized detailed biochemical and enzymology techniques to identify inhibitors of fungal GGTase and IkBa ubiquitin ligases.

Marc Pelletier

Biochemist/Cell Biologist with +20 years of biomedical research experience in industry settings, wor...
Suffolk County, Massachusetts, United States

*50 free lookup(s) per month.

No credit card required.

Marc Pelletier’s Email marc.pelletier@novartis.com

Marc Pelletier’s Phone Numbers

Get MARC’s Phone Number (For Free)

Social Media

Marc Pelletier’s Location Suffolk County, Massachusetts, United States

Marc Pelletier’s Current Industry Novartis Institutes For Biomedical Research

Not the Marc Pelletier you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Novartis Institutes For Biomedical Research

Translational Immune Oncology, Associate Director

2023-04-01 00:00:00 - Present

Merck

Immune Oncology, Associate Principal Scientist

2012-10-01 00:00:00 - 2014-08-01 00:00:00

Merck Research Labs

Oncology, Sr. Research Biologist

2006-05-01 00:00:00 - 2012-10-01 00:00:00

Biogen

Scientist I

2003-01-01 00:00:00 - 2006-01-01 00:00:00

Biogen Idec

Research Associate III

1999-01-01 00:00:00 - 2003-01-01 00:00:00

Mitotix

Research Associate II

1996-01-01 00:00:00 - 1999-01-01 00:00:00

Tib Molbiol

Technician and Customer Support

1994-01-01 00:00:00 - 1995-01-01 00:00:00

Max Planck Institute For Human Genetics

Research Technician

1989-01-01 00:00:00 - 1994-01-01 00:00:00

Harvard Dept Of Molecular Biology

Research Technician

1987-01-01 00:00:00 - 1989-01-01 00:00:00

Massachusetts Eye And Ear Infirmary

Research Technician

1985-01-01 00:00:00 - 1987-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Marc Pelletier

Marc Pelletier is located at
Suffolk County, Massachusetts, United States

Marc Pelletier is a Biochemist/Cell Biologist with +20 years of biomedical research experience in industry settings, working on oncology, auto-immune and anti-fungal targets. Currently discovering, developing and implementing translational biomarkers of target engagement and patient stratification for clinical trials in immune oncology. Experienced in assay development to discover small molecule and protein therapeutics. Effective communicator, highly collaborative, engaging colleagues with complementary skills and knowledge to achieve project goals and timelines. Record of taking on and completing difficult projects: • Discovered and developed clinical biomarkers that have demonstrated pathway modulation in biopsies and sera from PhI trials of novel immune oncology molecules. • Designed and conducted experiments using preclinical models and human samples which led to translatable pharmacodynamic biomarkers for tumor autologous and microenvironment targets. • Developed a novel homologous recombination quantitative assay to support the PARP inhibitor Niraparib. • Developed scalable purification strategies and HTS amenable assays for multi-subunit enzyme complexes and high molecular weight kinases. • Published detailed comparison of two BAFF pathway decoy receptors used to assess putative drug candidates. • Utilized detailed biochemical and enzymology techniques to identify inhibitors of fungal GGTase and IkBa ubiquitin ligases.

Marc Pelletier currently works in the Novartis Institutes For Biomedical Research |

No Languages Available

Marc Pelletier has prior
experience in the following industries:
Merck | Merck Research Labs | Biogen | Biogen Idec | Mitotix | Tib Molbiol | Max Planck Institute For Human Genetics | Harvard Dept Of Molecular Biology | Massachusetts Eye And Ear Infirmary

Marc Pelletier has the following professional experience:
Novartis Institutes For Biomedical Research | Merck | Merck Research Labs | Biogen | Biogen Idec | Mitotix | Tib Molbiol | Max Planck Institute For Human Genetics | Harvard Dept Of Molecular Biology | Massachusetts Eye And Ear Infirmary